SGLT-2 Inhibitor Effects on Cardiac and Hepatic Metabolic Profiles for the Diabetes Patients Combined With Obesity
Clinical trial NCT05764811 · COMPLETED
Trial details
- NCT number
- NCT05764811
- Sponsor
- National Cheng-Kung University Hospital
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-06
- Primary completion
- 2022-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.